Navigation Links
Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
Date:6/25/2012

BEIJING, June 25, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today provided an update on its Phase III clinical trial progress and commercialization preparation for its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and mouth disease (HFMD).

EV71 Clinical Trial

The double-blinded, randomized, placebo controlled Phase III trial is being conducted at three sites across China's Jiangsu province. This study is designed to demonstrate the efficacy of the EV71 vaccine in the prevention of the diseases caused by EV71 in infants 6 to 35 months old. About 10,000 healthy infants completed the vaccination schedule in the first quarter of 2012, prior to the epidemic season for HFMD in China. The disease surveillance period began 28 days after completion of the two-dose regimen.

A three arm active surveillance system, comprised of village health clinics, township hospitals, and local county Centers for Disease Control and Prevention (CDC), has been established at each clinical site and is in charge of epidemic surveillance, case diagnosis, epidemiological survey, and sample collection.  

When a case is identified by village or township doctors, throat swabs and anal swabs are collected from the patient. Physicians from the CDC then make visits to examine the child, record information and collect additional specimens for further tests. All samples are immediately sent to the laboratories for virus identification. A part of blinded samples are sent to the national CDC laboratory for confirming the previous testing results. According to the trial protocol, the Data and Safety Monitoring Board (DSMB) will review the clinical and laboratory results and confirm the diagnosis of EV71-associated disease before unblinding.

A number of patients with HF
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sinovac Reports Unaudited First Quarter 2012 Financial Results
2. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
3. HealthWarehouse.com Reports 82% Year-Over-Year Revenue Growth
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012
6. GenVec Reports Inducement Award
7. China Kanghui Holdings Reports First Quarter 2012 Financial Results
8. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
9. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
10. Patient Safety Technologies Reports First Quarter 2012 Results
11. Nephros Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... LOS ANGELES , July 24, 2014 Many ... what they can do to ensure that their practice will ... dentists purchase the basic supplies they use the most can ... other, and many dentists have recently discovered that purchasing ... and loss. According to successful dentists across ...
(Date:7/24/2014)... July 24, 2014 LSI Medience Corporation ... Agreement with Kineticos, a Raleigh-Durham, NC ... will support LSI Medience in identifying opportunities for ... demonstrate utility in clinical trials. The ... in diagnosis of sepsis, prognosis of septic patients, ...
(Date:7/24/2014)... 24, 2014  Kinex Pharmaceuticals announced the receipt of ... KX2-391 Ointment for the commencement of a Phase I ... third IND to be allowed by the US FDA ... a synthetic, orally active and highly selective inhibitor of ... the induction of p53, G2/M arrest of proliferating cell ...
Breaking Medicine Technology:Dental Supplies Online is Key to Dental Success...Really! 2LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... New York City Health and Hospitals Corporation (HHC) ... Executive 100 for a joint project that helped transform HHC,s ... Great Supply Chain Projects," highlights supply chain transformation projects that ... Three years ago, HHC faced a billion-dollar deficit and ...
... 2011 Rapid Fire Marketing (Pink Sheets: ... company, Medical Cannabis Management (MCM) is taking steps ... MCM provides marketing, consulting and management services and has recently ... of medical cannabis. Now MCM is looking to expand operations ...
Cached Medicine Technology:Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executive's 2011 Executive 100 2Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executive's 2011 Executive 100 3Rapid Fire Marketing's Medical Cannabis Management Looking to Expand Business 2
(Date:7/25/2014)... Steven Reinberg HealthDay Reporter , ... number of girls and boys are getting the human papillomavirus ... U.S. health officials said Thursday. The U.S. Centers for ... 11 and 12 get the three-dose vaccine so that protection ... Yet, despite a slight increase over the year ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Project Ninety ... episode of Innovations with Ed Begley Jr, airing later ... times TBA. , For more than four decades, Project ... Area community through its residential alcohol and substance abuse ... on Project Ninety's humble idea and how it has ...
(Date:7/25/2014)... July 25, 2014 ZeptoMetrix™ Corporation ... reliable and trusted products and services for infectious ... release of NATtrol™ RP Multimarker Controls - ... in vitro diagnostic, CE marked, unassayed external run ... assays the NATtrol™ RP Multimarker Controls - MDZ001 ...
(Date:7/25/2014)... Brighton, MI (PRWEB) July 25, 2014 In ... political uncertainty, it’s no surprise that Americans may not be ... with it, according to a new poll conducted by ... 200 consumers from across the country, “Which Political Party Do ... Night?” found that those registered as Independents tout a higher ...
(Date:7/25/2014)... NY (PRWEB) July 25, 2014 Ticket ... the Guinness International Champions Cup Match between Manchester City ... New York, one of the most iconic locations is Yankee ... Yankee Stadium, but it is quickly becoming a location that ... facility is home to the New York Yankees from Major ...
Breaking Medicine News(10 mins):Health News:Too Few Teens Receive HPV Shot, CDC Says 2Health News:Too Few Teens Receive HPV Shot, CDC Says 3Health News:Project Ninety to be Featured on Innovations with Ed Begley, Jr. 2Health News:Project Ninety to be Featured on Innovations with Ed Begley, Jr. 3Health News:ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls 2Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 2Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 3Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 3
... Saint Louis University researcher confirms findings that about half of ... causes them to metabolize food// differently, putting them at greater ... assistant professor of nutrition and dietetics at Doisy College of ... common version of a gene called FABP2, which is involved ...
... conclusively that a neuropeptide, melanin concentrating hormone (MCH), found ... increasing appetite in people, plays a role in the ... insulin. This finding has the potential to spur the ... production of insulin-producing beta cells in the pancreas. ...
... Complications due to drinking during pregnancy can range from ... severe and possibly greater-occurring Fetal Alcohol// Spectrum Disorders. The ... and type, all appear to be crucial elements of ... 80 percent of non-Indigenous West Australian women consumed alcohol ...
... six global acquisitions last year, India's Ranbaxy Laboratories has entered ... German// pharmaceuticals major Merck in a deal estimated at over ... equity funds to finance the deal,’ Ranbaxy's chief executive Malvinder ... the World Economic Forum (WEF) here. ‘We are being hounded ...
... Varenicline is the first new anti-smoking drug in the last ... to be licensed in the USA for smoking cessation. ... for use in the UK on 5th December 2006. An ... give a three-fold increase in the odds of a person ...
... number of women aged 40 and older are getting mammography ... more breast cancer deaths down the line, according to concerned ... 1990s, and scientists are disturbed about this decline. ... a test that's been around for a long time, it's ...
Cached Medicine News:Health News:Role of Appetite Hormone MCH in Insulin Production Revealed 2Health News:Risk Factors of Drinking Before, and During, Pregnancy 2Health News:Mammography Saves Life-Beware Women Over 40 2
The True Non-Compliant Balloon....
... Medical's universal programmer platform, the Model ... combination with St. Jude Medical® bradycardia ... emerging indications. Features a large, ... matrix LCD screen Programmer offers continuous, ...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... Digital Multichannel, with it's streamlined ... of routine laboratory tasks. The ... features: Soft-touch tip ejection, Super ... (0.5-10ul models), Entire pipette autoclavable, ...
Medicine Products: